Stay updated on TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.5.0 is now displayed, replacing the previous Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T20:28:48.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Additions were recorded on 2026-03-09, 2026-03-05, and 2026-03, and deletions were recorded on 2025-08-07, 2025-08-04, and 2025-08.
    Difference
    0.2%
    Check dated 2026-03-14T13:35:27.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces v3.4.2 on the page. No user-facing content or functionality is altered.
    Difference
    0.0%
    Check dated 2026-03-07T12:57:00.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    A minor version update was applied, from v3.4.1 to v3.4.2, with no changes to the displayed study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T13:40:51.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-05T17:12:16.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed.
    Difference
    0.0%
    Check dated 2026-01-15T04:16:51.000Z thumbnail image

Stay in the know with updates to TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page.